| Phen2Gene: rapid phenotype-driven gene prioritization for rare diseases M Zhao, JM Havrilla, L Fang, Y Chen, J Peng, C Liu, C Wu, M Sarmady, ... NAR genomics and bioinformatics 2 (2), lqaa032, 2020 | 56 | 2020 |
| Multiplex gene and phenotype network to characterize shared genetic pathways of epilepsy and autism J Peng, Y Zhou, K Wang Scientific reports 11 (1), 1-16, 2021 | 37 | 2021 |
| Natural language processing (NLP) tools in extracting biomedical concepts from research articles: a case study on autism spectrum disorder J Peng, M Zhao, J Havrilla, C Liu, C Weng, W Guthrie, R Schultz, K Wang, ... BMC Medical Informatics and Decision Making 20 (11), 1-9, 2020 | 23 | 2020 |
| Development of a phenotype ontology for autism spectrum disorder by natural language processing on electronic health records M Zhao, J Havrilla, J Peng, M Drye, M Fecher, W Guthrie, B Tunc, ... Journal of Neurodevelopmental Disorders 14 (1), 1-12, 2022 | 9 | 2022 |
| Expediting knowledge acquisition by a web framework for Knowledge Graph Exploration and Visualization (KGEV): case studies on COVID-19 and Human Phenotype Ontology J Peng, D Xu, R Lee, S Xu, Y Zhou, K Wang BMC Medical Informatics and Decision Making 22 (2), 1-14, 2022 | 6 | 2022 |
| Unsupervised and supervised discovery of tissue cellular neighborhoods from cell phenotypes Y Hu, J Rong, Y Xu, R Xie, J Peng, L Gao, K Tan Nature Methods, 1-12, 2024 | 4 | 2024 |
| Molecular de-extinction of antibiotics enabled by deep learning F Wan, MDT Torres, J Peng, C de la Fuente bioRxiv, 2023.10. 01.560353, 2023 | 4 | 2023 |
| Learning predictive models of tissue cellular neighborhoods from cell phenotypes with graph pooling Y Hu, J Rong, R Xie, Y Xu, J Peng, L Gao, K Tan bioRxiv, 2022.11. 06.515344, 2022 | 2 | 2022 |
| Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia K Tan, J Xu, C Chen, T Vincent, P Pölönen, J Hu, S Yoshimura, W Yu, ... | 1 | 2023 |
| Progenitor Sub-Populations in Treatment Resistant T-ALL J Xu, C Chen, TL Vincent, P Pölönen, A Elsayed, J Hu, S Yoshimura, ... Blood 140 (Supplement 1), 1724-1726, 2022 | 1 | 2022 |
| Checkpoint Immunotherapy Is Associated with Preferential Activation of Tumor-Antigen Specific CD4+ T Cells in MDS EA Griffiths, P Srivastava, EC Gomez, J Matsuzaki, K Odunsi, LW Dillon, ... Blood 142, 4602, 2023 | | 2023 |
